The Food and Drug Administration has changed some statements in its Device Approvals and Clearances section for the SYSTEM 1E Liquid Chemical Sterilant Processing System manufactured by STERIS Corporation.
The revised language reads as follows: "The rinse water is tap (potable) water that has been filtered and exposed to ultraviolet rays. It is treated to minimize bioburden that may be naturally occurring in the water. The treatment method eliminates bacteria/fungi/protozoa from the water. Studies with the test virus MS2 (EPA recommended surrogate for waterborne viruses) showed a 6 log reduction."
To access the FDA document, CLICK HERE.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.